Medicaid Pharmacy Management Program Improves Patient Care While Saving Eight States Almost $95 Million
INDIANAPOLIS, June 8 /PRNewswire-FirstCall/ -- An eight-state study of the award-winning Behavioral Pharmacy Management Program (BPM) shows the private-public Medicaid partnership program has helped improve patient care while saving eight states almost $95 million in behavioral health pharmaceutical costs.(1)
Lilly funds the program, which is designed and run by research firm Comprehensive NeuroScience, Inc. (CNS) at the sole direction and guidance of state Medicaid departments. The BPM, which has been executed in more than half of the states, has won a variety of national awards, including the Substance Abuse and Mental Health Services Administration Science and Service Award, URAC Silver Award for Best Practices in Consumer Empowerment and Protection, American Psychiatric Association Bronze Achievement Award and Disease Management Association of America Gold Award.
Missouri, one of the states included in the study, has seen significant improvements in patient care, as well as Medicaid cost savings.(2)
"We need to make sure we take the very best care of the Medicaid patients we serve and help them understand how to take the very best care of themselves. With the BPM, we have the opportunity to do that by simply targeting best practices and making educational information available to physicians, so they understand the best practice alternatives. We believe that, if you do the right things, the cost will follow and it has," said George Oestreich, deputy division director, Clinical Services, MO HealthNet Division.
"Controlling health care costs and improving quality is a big, complicated issue. These kinds of partnerships, which pursue quality as a way to contain costs, are really going to be the solution to a lot of the health care problems that America faces," said
'/>"/>
| SOURCE Eli Lilly and Company Copyright©2009 PR Newswire. All rights reserved |